Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas J Hermes

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 20, 2016
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex SlicesChangqing Xu, Douglas J Hermes, Ken Mackie, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 10, 2015
Mechanisms of Functional Hypoconnectivity in the Medial Prefrontal Cortex of Mecp2 Null MiceMichael P Sceniak, Min Lang, Addison C Enomoto, et al.
Molecular and Cellular Neurosciences|July 23, 2017
Endocannabinoids exert CB<sub>1</sub> receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat proteinChangqing Xu, Douglas J Hermes, Blessing Nwanguma, et al.
Neuropharmacology|August 17, 2018
Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDSDouglas J Hermes, Changqing Xu, Justin L Poklis, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 3, 2019
Inhibitory Control Deficits Associated with Upregulation of CB<sub>1</sub>R in the HIV-1 Tat Transgenic Mouse Model of HandIan R Jacobs, Changqing Xu, Douglas J Hermes, et al.
Experimental Neurology|March 19, 2021
GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegenerationDouglas J Hermes, Barkha J Yadav-Samudrala, Changqing Xu, et al.
Frontiers in Neurology|September 6, 2021
Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 TatAlexis F League, Benjamin L Gorman, Douglas J Hermes, et al.
Journal of Neuroinflammation|November 19, 2020
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acidsDouglas J Hermes, Ian R Jacobs, Megan C Key, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 20, 2016
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex SlicesChangqing Xu, Douglas J Hermes, Ken Mackie, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 10, 2015
Mechanisms of Functional Hypoconnectivity in the Medial Prefrontal Cortex of Mecp2 Null MiceMichael P Sceniak, Min Lang, Addison C Enomoto, et al.
Molecular and Cellular Neurosciences|July 23, 2017
Endocannabinoids exert CB<sub>1</sub> receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat proteinChangqing Xu, Douglas J Hermes, Blessing Nwanguma, et al.
Neuropharmacology|August 17, 2018
Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDSDouglas J Hermes, Changqing Xu, Justin L Poklis, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 3, 2019
Inhibitory Control Deficits Associated with Upregulation of CB<sub>1</sub>R in the HIV-1 Tat Transgenic Mouse Model of HandIan R Jacobs, Changqing Xu, Douglas J Hermes, et al.
Experimental Neurology|March 19, 2021
GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegenerationDouglas J Hermes, Barkha J Yadav-Samudrala, Changqing Xu, et al.
Frontiers in Neurology|September 6, 2021
Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 TatAlexis F League, Benjamin L Gorman, Douglas J Hermes, et al.
Journal of Neuroinflammation|November 19, 2020
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acidsDouglas J Hermes, Ian R Jacobs, Megan C Key, et al.
Pageof 1